The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
Adv Rheumatol; 61 (), 2021
Abstract Background: To assess the prevalence and clinical relevance of anti-Jo-1 autoantibodies in a representative sample of patients with definite dermatomyositis (DM). Methods: This retrospective cohort study took place from 2005 to 2020 and assessed 118 adult patients from a tertiary center who we...